Epidemiology of non-AD dementias

Abstract Dementia is a common neurodegenerative disorder that affects about 10% of the population over 65 years of age. A distinction can be made between primary degenerative dementias and dementia secondary to other diseases. This review focuses on the primary non-Alzheimer's disease (AD) dementias: vascular dementia (VaD), dementia with Lewy bodies (DLB) and frontotemporal dementia (FTD). VaD is after AD most frequent subtype of dementia with a prevalence of about 1%, ranging from 0 to 10% mainly depending on the age group investigated and the criteria used. Its incidence rate is between 1.5 and 4.1 per 1000 person-years, with no clear difference between men and women and with possibly a higher incidence in East Asia compared to Canada and Europe. Most of the VaD cases are sporadic although there are some rare familial forms of VaD as cerebral autosomal dominant arteriopathy with subcortical infarctions and leukoencephalopathy and familial cerebral amyloid angiopathy. Important risk factors for sporadic VaD are cerebrovascular pathology (brain infarction, white matter lesions and brain atrophy), midlife hypertension, and diabetes leading to increasing risk ratios. A protective effect is often found for education and moderate use of alcohol. The association between VaD and amyloid β, cholesterol, and statin use remains unclear yet. DLB and FTD are less frequent forms of dementia with prevalence rates of, respectively, 0.1–0.6 and 0.002–0.015%. FTD affects people in their middle age, accounting for up to 10–20% of the presenile dementia cases. About 14% of the FTD cases are caused by an autosomal dominant tau-mutation. However, since the prevalence of sporadic FTD is relatively low, population-based epidemiological studies are hard to perform and no non-genetic risk factors are known yet. DLB is a relative common form of dementia in old age accounting for 15–20% of cases in hospital autopsy case-series. The only known possible risk factor for DLB is the presence of an apolipoprotein E e4 allele.

[1]  A. Hofman,et al.  Diet and risk of dementia: Does fat matter? , 2002, Neurology.

[2]  A. Hofman,et al.  The prevalence of vascular dementia in europe: Facts and fragments from 1980–1990 studies , 1991, Annals of neurology.

[3]  Hitoshi Takahashi,et al.  Clinical features of familial diffuse Lewy body disease. , 1997, European neurology.

[4]  P. Mcgeer,et al.  The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases , 1995, Brain Research Reviews.

[5]  E. Barrett-Connor,et al.  Serum lipoprotein levels, statin use, and cognitive function in older women. , 2002, Archives of neurology.

[6]  P. O'Brien,et al.  Risk of dementia among persons with diabetes mellitus: a population-based cohort study. , 1997, American journal of epidemiology.

[7]  A. Goate,et al.  Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer's disease , 1996, The Lancet.

[8]  M. Viitanen,et al.  CADASIL: a Common Form of Hereditary Arteriopathy Causing Brain Infarcts and Dementia , 2002, Brain pathology.

[9]  C. K. Liu,et al.  Incidence and subtypes of dementia in southern Taiwan Impact of socio‐demographic factors , 1998, Neurology.

[10]  M. Bullido,et al.  APOE genotype in cerebrovascular disease and vascular dementia , 2002, Journal of the Neurological Sciences.

[11]  P. Amouyel,et al.  The deletion allele of the angiotensin I converting enzyme gene as a genetic susceptibility factor for cognitive impairment , 1996, Neuroscience Letters.

[12]  M. Hutton,et al.  The molecular genetics of the tauopathies , 2000, Experimental Gerontology.

[13]  J. Littleton,et al.  Inhibition of Platelet Aggregation by Ethanol in Vitro Shows Specificity for Aggregating Agent Used and Is Influenced by Platelet Lipid Composition , 1982, Thrombosis and Haemostasis.

[14]  M. Hennerici,et al.  Are gait disturbances and white matter degeneration early indicators of vascular dementia? , 1994, Dementia.

[15]  P. Winocour,et al.  Serum paraoxonase activity in familial hypercholesterolaemia and insulin-dependent diabetes mellitus. , 1991, Atherosclerosis.

[16]  J. Morris,et al.  Apolipoprotein E genotype does not affect the age of onset of dementia in families with defined tau mutations , 1999, Neuroscience Letters.

[17]  D. Geschwind,et al.  The apolipoprotein E ε4 allele is not a significant risk factor for frontotemporal dementia , 1998 .

[18]  M. Greicius,et al.  Presenile dementia syndromes: an update on taxonomy and diagnosis , 2002, Journal of neurology, neurosurgery, and psychiatry.

[19]  A. Hofman,et al.  Incidence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. , 2000, Neurology.

[20]  E. Rimm,et al.  Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine, or spirits? , 1996, BMJ.

[21]  M. Ferrari,et al.  Subcortical lacunar lesions: an MR imaging finding in patients with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. , 2002, Radiology.

[22]  H. Markus,et al.  Angiotensin-converting enzyme gene deletion polymorphism. A new risk factor for lacunar stroke but not carotid atheroma. , 1995, Stroke.

[23]  P. Schnohr,et al.  Mortality associated with moderate intakes of wine, beer, or spirits , 1995, BMJ.

[24]  R. Mayeux,et al.  Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. , 2001, American journal of epidemiology.

[25]  P. Gorelick,et al.  Risk Factors for Dementia Associated With Multiple Cerebral Infarcts: A Case-Control Analysis in Predominantly African-American Hospital-Based Patients , 1993 .

[26]  G. Boers,et al.  Heterozygosity for homocystinuria in premature peripheral and cerebral occlusive arterial disease. , 1985, The New England journal of medicine.

[27]  S. Levine,et al.  Quantitative MRI findings and cognitive impairment among community dwelling elderly subjects , 2002, Journal of neurology, neurosurgery, and psychiatry.

[28]  S. Li,et al.  A three‐year follow‐up study of age‐related dementia in an urban area of Beijing , 1991, Acta psychiatrica Scandinavica.

[29]  Matthijs Oudkerk,et al.  Incidence and Risk Factors of Silent Brain Infarcts in the Population-Based Rotterdam Scan Study , 2003, Stroke.

[30]  B. Lernfelt,et al.  15-year longitudinal study of blood pressure and dementia , 1996, The Lancet.

[31]  M. Viitanen,et al.  Increased risk for frontotemporal dementia through interaction between tau polymorphisms and apolipoprotein E epsilon4. , 2001, Neuroreport.

[32]  D. Neary,et al.  Apolipoprotein E ϵ4 Allele Has No Effect on Age at Onset or Duration of Disease in Cases of Frontotemporal Dementia with Pick- or Microvacuolar-Type Histology , 2000, Experimental Neurology.

[33]  A Hofman,et al.  Gender differences in the incidence of AD and vascular dementia , 1999, Neurology.

[34]  S. Tsuji,et al.  Autosomal dominant diffuse Lewy body disease , 1998, Acta Neuropathologica.

[35]  A. Hofman,et al.  Education and the incidence of dementia in a large population-based study: The Rotterdam Study , 1999, Neurology.

[36]  D. Siscovick,et al.  Alcohol Consumption and Subclinical Findings on Magnetic Resonance Imaging of the Brain in Older Adults: The Cardiovascular Health Study , 2001, Stroke.

[37]  I. Skoog,et al.  Seven-year survival rate after age 85 years: relation to Alzheimer disease and vascular dementia. , 1998, Archives of neurology.

[38]  N. Bornstein,et al.  APOE-ε4 in Patients with Alzheimer Disease and Vascular Dementia , 1996 .

[39]  M. Rossor,et al.  The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases , 1999, Journal of neurology, neurosurgery, and psychiatry.

[40]  T. Bird,et al.  Familial dementia with lewy bodies: a clinical and neuropathological study of 2 families. , 2002, Archives of neurology.

[41]  S. Berg,et al.  The influence of white matter lesions on neuropsychological functioning in demented and non‐demented 85‐year‐olds , 1996, Acta neurologica Scandinavica.

[42]  E. Perry,et al.  Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease. , 1994, The American journal of pathology.

[43]  L. White,et al.  A longitudinal study of drinking and cognitive performance in elderly Japanese American men: the Honolulu-Asia Aging Study. , 2000, American journal of public health.

[44]  L. Kuller Prevention of cardiovascular disease and the future of cardiovascular disease epidemiology. , 2001, International journal of epidemiology.

[45]  J. Klein,et al.  Stimulatory and inhibitory effects of ethanol on hippocampal acetylcholine release , 1998, Naunyn-Schmiedeberg's Archives of Pharmacology.

[46]  S. Adkins,et al.  Molecular basis for the polymorphic forms of human serum paraoxonase/arylesterase: glutamine or arginine at position 191, for the respective A or B allozymes. , 1993, American journal of human genetics.

[47]  Albert Hofman,et al.  Alcohol consumption and risk of dementia: the Rotterdam Study , 2002, The Lancet.

[48]  A. Hofman,et al.  Blood Pressure and Risk of Dementia: Results from the Rotterdam Study and the Gothenburg H-70 Study , 2000, Dementia and Geriatric Cognitive Disorders.

[49]  E. Braak,et al.  Advanced glycation endproducts are associated with Hirano bodies in Alzheimer's disease , 1998, Brain Research.

[50]  R. Mayeux,et al.  Low-density lipoprotein cholesterol and the risk of dementia with stroke. , 1999, JAMA.

[51]  L. Launer,et al.  Cerebral amyloid angiopathy and cognitive function: The HAAS autopsy study , 2002, Neurology.

[52]  T. Dantoine,et al.  Paraoxonase as a Risk Marker for Cardiovascular Disease: Facts and Hypotheses , 1998, Clinical chemistry and laboratory medicine.

[53]  M. Sjögren,et al.  The prevalence of frontal variant frontotemporal dementia and the frontal lobe syndrome in a population based sample of 85 year olds , 2003, Journal of neurology, neurosurgery, and psychiatry.

[54]  M. Blatter,et al.  Identification of a distinct human high-density lipoprotein subspecies defined by a lipoprotein-associated protein, K-45. Identity of K-45 with paraoxonase. , 1993, European journal of biochemistry.

[55]  J. Lindsay,et al.  The Canadian Study of Health and Aging: risk factors for vascular dementia. , 1997, Stroke.

[56]  P. de Knijff,et al.  Apolipoprotein E gene and sporadic frontal lobe dementia , 1997, Neurology.

[57]  J R Hodges,et al.  The prevalence of frontotemporal dementia , 2002, Neurology.

[58]  J. Buring,et al.  Light-to-moderate alcohol consumption and the risk of stroke among U.S. male physicians. , 1999, The New England journal of medicine.

[59]  J. Lalouel,et al.  Association of genetic variations in apolipoprotein B with hypercholesterolemia, coronary artery disease, and receptor binding of low density lipoproteins. , 1997, Journal of lipid research.

[60]  B. Dubois,et al.  Association between the extended tau haplotype and frontotemporal dementia. , 2002, Archives of neurology.

[61]  C. Katona,et al.  Three years survival in patients with a clinical diagnosis of dementia with Lewy bodies , 2000, International journal of geriatric psychiatry.

[62]  W. Jagust,et al.  Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers , 1992, Neurology.

[63]  S. Xiao,et al.  A preliminary analysis of incidence of dementia in Shanghai, China , 1998, Psychiatry and clinical neurosciences.

[64]  Monique M. B. Breteler,et al.  Incidence of dementia: does gender make a difference? , 2001, Neurobiology of Aging.

[65]  J. Jolles,et al.  Comparison of seven sets of criteria used for the diagnosis of vascular dementia. , 1996, Neuroepidemiology.

[66]  P. Scheltens,et al.  Familial aggregation in frontotemporal dementia , 1998, Neurology.

[67]  G. Román Diagnosis of vascular dementia and Alzheimer's disease. , 2001, International journal of clinical practice. Supplement.

[68]  E. Feskens,et al.  Smoking, drinking, and thinking. The Zutphen Elderly Study. , 1996, American journal of epidemiology.

[69]  G. Zuliani,et al.  Genetic polymorphisms in older subjects with vascular or Alzheimer's dementia , 2001, Acta neurologica Scandinavica.

[70]  T M Hayes,et al.  Associations of alcohol consumption with plasma high density lipoprotein cholesterol and its major subfractions: the Caerphilly and Speedwell Collaborative Heart Disease Studies. , 1988, Journal of epidemiology and community health.

[71]  D. Knopman,et al.  Survival study of vascular dementia in Rochester, Minnesota. , 2003, Archives of neurology.

[72]  M. Breteler,et al.  Vascular risk factors for Alzheimer’s disease: An epidemiologic perspective , 2000, Neurobiology of Aging.

[73]  M. Kokai,et al.  Familial dementia with Lewy bodies (DLB). , 1999, Clinical neuropathology.

[74]  J. Berliner,et al.  Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. , 1995, The Journal of clinical investigation.

[75]  Skidgel Ra,et al.  The angiotensin I-converting enzyme. , 1977 .

[76]  Curt D. Furberg,et al.  Incidence, Manifestations, and Predictors of Brain Infarcts Defined by Serial Cranial Magnetic Resonance Imaging in the Elderly: The Cardiovascular Health Study , 2002, Stroke.

[77]  Oscar L. Lopez,et al.  Risk Factors for Dementia in the Cardiovascular Health Cognition Study , 2003, Neuroepidemiology.

[78]  G. Schellenberg,et al.  Apolipoprotein E genotype and Alzheimer's disease , 1993, The Lancet.

[79]  Y. Yamori,et al.  Prevalence of Alzheimer's disease, vascular dementia and dementia with Lewy bodies in a Japanese population , 2001, Psychiatry and clinical neurosciences.

[80]  D. Tomassoni,et al.  Protective effect of anti-hypertensive treatment on cognitive function in essential hypertension Analysis of published clinical data , 2002, Journal of the Neurological Sciences.

[81]  L. Launer,et al.  Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study. , 2002, Diabetes.

[82]  A. Hofman,et al.  Non-insulin-dependent Diabetes Mellitus (niddm) Association of Diabetes Mellitus and Dementia: the Rotterdam Study , 2022 .

[83]  M. Freedman,et al.  Frontotemporal lobar degeneration , 1998, Neurology.

[84]  K. Asplund,et al.  Diabetes as a risk factor for stroke. A population perspective , 1995, Diabetologia.

[85]  Diederick E Grobbee,et al.  Prevalence of Alzheimer's disease and vascular dementia: association with education. The Rotterdam study , 1995, BMJ.

[86]  J. Lindsay,et al.  Vascular dementia : incidence and risk factors in the Canadian study of health and aging. , 2000, Stroke.

[87]  R. Havlik,et al.  The association between midlife blood pressure levels and late-life cognitive function. The Honolulu-Asia Aging Study. , 1995, JAMA.

[88]  N. Bornstein,et al.  ACE, MTHFR, factor V Leiden, and APOE polymorphisms in patients with vascular and Alzheimer's dementia. , 1998, Stroke.

[89]  A Hofman,et al.  Diabetes mellitus and the risk of dementia , 1999, Neurology.

[90]  M. Etminan,et al.  The Role of Lipid‐Lowering Drugs in Cognitive Function: A Meta‐Analysis of Observational Studies , 2003, Pharmacotherapy.

[91]  I. McKeith Dementia with Lewy bodies , 2002, British Journal of Psychiatry.

[92]  R. D'Agostino,et al.  Untreated blood pressure level is inversely related to cognitive functioning: the Framingham Study. , 1993, American journal of epidemiology.

[93]  A. Hofman,et al.  Antihypertensive drugs and incidence of dementia: the Rotterdam Study , 2001, Neurobiology of Aging.

[94]  S. Rosso Frontotemporal Dementia in the Netherlands , 2003 .

[95]  L M Schuman,et al.  A case-control study of dementia of the Alzheimer type. , 1985, American journal of epidemiology.

[96]  L R White,et al.  Longitudinally measured blood pressure, antihypertensive medication use, and cognitive performance: the Framingham Study. , 1990, Journal of clinical epidemiology.

[97]  R. Roos,et al.  Hereditary cerebral hemorrhage with amyloidosis--Dutch type (HCHWA-D): a review of the variety in phenotypic expression. , 1999, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[98]  Charles DeCarli,et al.  APOE-ε4 is associated with less frontal and more medial temporal lobe atrophy in AD , 1999, Neurology.

[99]  R. Katzman.,et al.  Education and the prevalence of dementia and Alzheimer's disease , 1993, Neurology.

[100]  J. Mohr,et al.  The natural history of CADASIL: a pooled analysis of previously published cases. , 1999, Stroke.

[101]  H. Arai,et al.  Presenilin-1 Polymorphism in Alzheimer's Disease and Vascular Dementia , 1997, Experimental Neurology.

[102]  M. L. Fravolini,et al.  Angiotensin converting enzyme deletion allele in different kinds of dementia disorders , 1999, Neuroscience Letters.

[103]  B. Winblad,et al.  Mortality from dementia in advanced age: a 5-year follow-up study of incident dementia cases. , 1999, Journal of clinical epidemiology.

[104]  D. Commenges,et al.  Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. , 1997, Revue neurologique.

[105]  R Doll,et al.  Smoking and dementia in male British doctors: prospective study , 2000, BMJ : British Medical Journal.

[106]  W. Frishman Are antihypertensive agents protective against dementia? A review of clinical and preclinical data. , 2002, Heart disease.

[107]  A. Singleton,et al.  Clinical and Neuropathological Correlates of Apolipoprotein E Genotype in Dementia with Lewy Bodies , 2002, Dementia and Geriatric Cognitive Disorders.

[108]  H S Markus,et al.  MRI hyperintensities of the temporal lobe and external capsule in patients with CADASIL , 2001, Neurology.

[109]  M. Idelson,et al.  The C677T Mutation in the Methylenetetrahydrofolate Reductase (MTHFR) Gene and Vascular Dementia , 2000, Journal of the American Geriatrics Society.

[110]  A. Hofman,et al.  Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study , 1997, The Lancet.

[111]  A. Hofman,et al.  Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study , 1998, The Lancet.

[112]  L. Kuller,et al.  Prospective study of alcohol consumption and risk of dementia in older adults. , 2003, JAMA.

[113]  B. Winblad,et al.  Very Old Women at Highest Risk of Dementia and Alzheimer's Disease , 1997, Neurology.

[114]  Hsuan-Cheng Huang,et al.  Apolipoprotein E polymorphism in various dementias in Taiwan Chinese population , 2002, Journal of Neural Transmission.

[115]  J. Biller,et al.  Cerebrovascular disorders in patients with diabetes mellitus. , 1996, Journal of diabetes and its complications.

[116]  B. Winblad,et al.  Low blood pressure and dementia in elderly people: the Kungsholmen project , 1996, BMJ.

[117]  M. Brown,et al.  How LDL receptors influence cholesterol and atherosclerosis. , 1984, Scientific American.

[118]  J Marshall,et al.  Cerebral blood flow in dementia. , 1975, Archives of neurology.

[119]  M. Cogné,et al.  Paraoxonase 1 192/55 Gene Polymorphisms in Alzheimer's Disease , 2002, Annals of the New York Academy of Sciences.

[120]  T. Wetterling,et al.  The ICD-10 criteria for vascular dementia. , 1994, Dementia.

[121]  P. Frosst,et al.  Molecular genetic analysis in mild hyperhomocysteinemia: a common mutation in the methylenetetrahydrofolate reductase gene is a genetic risk factor for cardiovascular disease. , 1996, American journal of human genetics.

[122]  H. Bickel,et al.  Incidence and relative risk of dementia in an urban elderly population: findings of a prospective field study , 1994, Psychological Medicine.

[123]  C. V. van Duijn,et al.  Apolipoprotein E4 in the temporal variant of frontotemporal dementia , 2002, Journal of neurology, neurosurgery, and psychiatry.

[124]  G. Lenzi,et al.  Serum lipoprotein pattern variations in dementia and ischemic stroke , 1990, Acta neurologica Scandinavica.

[125]  A. Hofman,et al.  Apolipoprotein E epsilon4 and the risk of dementia with stroke. A population-based investigation. , 1997, JAMA.

[126]  T. Truelsen,et al.  Amount and type of alcohol and risk of dementia , 2002, Neurology.

[127]  G. C. Román,et al.  Vascular dementia , 1993, Neurology.

[128]  E. Arbustini,et al.  Angiotensin converting enzyme gene deletion allele is independently and strongly associated with coronary atherosclerosis and myocardial infarction. , 1995, British heart journal.

[129]  C. Mamotte,et al.  Apolipoprotein ∈4 homozygosity in young men with coronary heart disease , 1992, The Lancet.

[130]  J. Kesslak Can estrogen play a significant role in the prevention of Alzheimer's disease? , 2002, Journal of neural transmission. Supplementum.

[131]  E. Perry,et al.  Multiple substrates of late-onset dementia: implications for brain protection. , 2001, Novartis Foundation symposium.

[132]  K. Kosaka,et al.  Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB) , 1996, Neurology.

[133]  R. Mayeux,et al.  Clinical determinants of dememtia related to stroke , 1993, Annals of neurology.

[134]  A. Hofman,et al.  Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. , 2000, Neurology.

[135]  K. Blennow,et al.  Cerebrospinal Fluid Beta-Amyloid 42 Is Reduced before the Onset of Sporadic Dementia: A Population-Based Study in 85-Year-Olds , 2003, Dementia and Geriatric Cognitive Disorders.

[136]  Janice L Holton,et al.  Sporadic and Familial Cerebral Amyloid Angiopathies , 2002, Brain pathology.

[137]  C. Duijn,et al.  Role of APOE in dementia: A critical reappraisal. , 1998 .

[138]  F. Boller,et al.  Apolipoprotein E ε4 allele frequency in demented and cognitively impaired patients with and without cerebrovascular disease , 2002, Journal of the Neurological Sciences.

[139]  L. Donini,et al.  DNA Polymorphisms of Apolipoprotein B and Angiotensin I-Converting Enzyme Genes and Relationships with Lipid Levels in Italian Patients with Vascular Dementia or Alzheimer’s Disease , 1998, Dementia and Geriatric Cognitive Disorders.

[140]  R. Zec,et al.  The Effects of Estrogen Replacement Therapy on Neuropsychological Functioning in Postmenopausal Women With and Without Dementia: A Critical and Theoretical Review , 2002, Neuropsychology Review.

[141]  R. Mayeux,et al.  Dementia after stroke , 1992, Neurology.

[142]  K. Svärdsudd,et al.  Age-related changes in blood pressure. , 1986, Hypertension.

[143]  N. Tachibana,et al.  Increased prevalence of vascular dementia in Japan , 2001, Neurology.

[144]  R. Havlik,et al.  Characterization of risk factors for vascular dementia , 1999, Neurology.

[145]  T. Wetterling,et al.  Comparison of different diagnostic criteria for vascular dementia (ADDTC, DSM-IV, ICD-10, NINDS-AIREN). , 1996, Stroke.

[146]  K. Nakashima,et al.  Estrogen Receptor Gene Polymorphisms in Patients with Alzheimer’s Disease, Vascular Dementia and Alcohol-Associated Dementia , 2000, Dementia and Geriatric Cognitive Disorders.

[147]  J. Thornby,et al.  Education and occupation as risk factors for dementias of the Alzheimer and ischemic vascular types. , 1995, Dementia.

[148]  J. V. van Swieten,et al.  New developments in frontotemporal dementia and parkinsonism linked to chromosome 17 , 2002, Current opinion in neurology.

[149]  A. McCall The Impact of Diabetes on the CNS , 1992, Diabetes.

[150]  L. Launer Demonstrating the case that AD is a vascular disease: epidemiologic evidence , 2002, Ageing Research Reviews.

[151]  C. Loeb,et al.  Dementia Associated With Lacunar Infarction , 1992, Stroke.

[152]  K. Blennow,et al.  Prevalence and Incidence of Clinically Diagnosed Memory Impairments in a Geographically Defined General Population in Sweden , 1999, Neuroepidemiology.

[153]  G. Livingston,et al.  Islington study of dementia subtypes in the community. , 2002, The British journal of psychiatry : the journal of mental science.

[154]  Broustet Jp Wine and health , 1999 .

[155]  K. Jellinger,et al.  The pathology of ischemic-vascular dementia An update , 2002, Journal of the Neurological Sciences.